May 12, 2022
Two prestigious additions to help Eagle Genomics deepen its presence in Food & Nutrition and AgBio - two industry verticals that will significantly benefit from the ongoing Bio Revolution CAMBRIDGE, UK – Eagle Genomics, the platform business pioneering the application of network science to biology across the Food and Nutrition, AgBio, Beauty and Personal Care, [...]
DANAHER JOINS BESPOKE GENE THERAPY CONSORTIUM (BGTC) FOR RARE DISEASES
May 12, 2022
Consortium aims to speed the development and delivery of customized or 'bespoke' gene therapies WASHINGTON -- Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate gene therapy resources that the research community can use to streamline gene therapy development for rare disorders, [...]
Jonathan Peacock Elected Chairman of the Board of Directors of Avantor®
May 12, 2022
RADNOR, Pa. , May 12, 2022 /PRNewswire/ -- The board of directors of Avantor, Inc. (NYSE: AVTR) a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries announced the election of Jonathan Peacock, 64, as chairman effective at the end of today's annual meeting of stockholders. Peacock, a [...]
DKSH Partners With CDR to Lead Food and Beverage Innovations in Thailand
May 12, 2022
DKSH will be the exclusive distributor of the CDR FoodLab® line of devices in Thailand, expanding their existing partnership with CDR S.r.l. beyond Taiwan. Bangkok – DKSH Business Unit Technology has signed an agreement with CDR to provide marketing and sales, application support, and after-sales services for the CDR FoodLab® series in Thailand, which cover a [...]
BLIRT CHANGES OWNERS; 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN
May 11, 2022
BLIRT SA, a biotech firm specializing in producing high-quality enzymes and reagents used in life sciences and global diagnostics, has changed its ownership structure. International biotech company QIAGEN has acquired over 96% of the shares of BLIRT. “Over recent years, we have intensively grown our business,” said Marian Popinigis, CEO of BLIRT SA. “We have invested, observed [...]
Cell Microsystems Names Industry Veterans as VP of Product Development and VP of Strategic Marketing
May 11, 2022
Aaron Kennington and Kap Kumar join the Company as VP of Product Development and VP of Strategic Marketing, respectively. DURHAM, NC, UNITED STATES -- Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows, announced today that Aaron Kennington and Kap Kumar joined the Company as VP of Product Development and VP of [...]
BICO Group adds senior IR manager to its executive management
May 11, 2022
Åsa Hillsten has been appointed SVP and Head of IR at BICO and will be a member of the company’s executive management This newly created position constitutes a step in BICO’s continued efforts to increase the service level to the market, improve the clarity of its communication and clarify its business model for the investor [...]
Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation
May 11, 2022
New funding will be used to advance Ionpath’s MIBI technology in translational research and precision medicine MENLO PARK, Calif. — Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being [...]
QIAGEN proposes expansion of Supervisory Board
May 11, 2022
Dr. Eva Pisa proposed as a new member to the Supervisory Board, contributes significant leadership experience in Life Science and Molecular Diagnostics industry All seven current Supervisory Board members to stand for re-election for one-year terms Annual General Meeting to be held on June 23, 2022, in Venlo, the Netherlands VENLO, the Netherlands -- QIAGEN [...]
QIAGEN acquires majority stake in enzymes provider BLIRT S.A.
May 11, 2022
BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents Strengthens QIAGEN’s sample technologies business, one of the company’s five pillars of growth, also with additional global production capacities and broader commercial reach 96% majority stake acquired in BLIRT S.A. through the transaction with a group [...]

